Theromics
Pre-clinicalTheromics is developing a next-generation thermal accelerant technology for enhanced ablation procedures and improved drug delivery.
Founded
2016
Focus
OncologyDrug Delivery
About
Theromics is developing a next-generation thermal accelerant technology for enhanced ablation procedures and improved drug delivery.
Funding History
2Total raised: $7M
Seed$5MUndisclosedJan 15, 2023
Grant$2MNational Institutes of Health (NIH)Mar 15, 2022
Company Info
TypePrivate
Founded2016
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile